FDA Inspection 831130 — Ajanta Pharma USA Inc.
The FDA completed an inspection of Ajanta Pharma USA Inc. on May 8, 2013 in Raritan, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 8, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Raritan, NJ (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)